Identification of patient-specific peptides for detection of M-proteins and myeloma cells.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 10583225)

Published in Br J Haematol on November 01, 1999

Authors

P B Szecsi1, E Riise, L B Roslund, J Engberg, I Turesson, L Buhl, C Schafer-Nielsen

Author Affiliations

1: Clinical Biochemistry, Roskilde County Hospital, Roskilde, Denmark.

Articles by these authors

International uniform response criteria for multiple myeloma. Leukemia (2006) 17.78

An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype typhimurium DT104. N Engl J Med (1999) 4.60

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia (2008) 3.41

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia (2010) 3.31

A case-control study of risk factors for sporadic campylobacter infections in Denmark. Epidemiol Infect (2003) 2.94

Origin of replication, oriC, of the Escherichia coli K12 chromosome: genetic mapping and minichromosome replication. Cold Spring Harb Symp Quant Biol (1979) 2.85

A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Nat Genet (1999) 2.85

Mice lacking all conventional MHC class II genes. Proc Natl Acad Sci U S A (1999) 2.83

Origin of replication, oriC, or the Escherichia coli chromosome on specialized transducing phages lambda asn. Mol Gen Genet (1978) 2.74

Validity of SmaI-defined genotypes of Campylobacter jejuni examined by SalI, KpnI, and BamHI polymorphisms: evidence of identical clones infecting humans, poultry, and cattle. Epidemiol Infect (1998) 2.50

Frequent good partial remissions from thalidomide including best response ever in patients with advanced refractory and relapsed myeloma. Br J Haematol (2000) 2.34

Free ribosomal DNA molecules from Tetrahymena pyriformis GL are giant palindromes. J Mol Biol (1976) 2.33

Low-dose hypersensitivity: current status and possible mechanisms. Int J Radiat Oncol Biol Phys (2001) 2.14

Dynamic effects of self-efficacy on smoking lapse and relapse. Health Psychol (2000) 1.93

Distribution of serotypes of Campylobacter jejuni and C. coli from Danish patients, poultry, cattle and swine. FEMS Immunol Med Microbiol (1997) 1.83

Scale and scope economies among health maintenance organizations. J Health Econ (1996) 1.68

Evaluation of phenotypic and genotypic methods for subtyping Campylobacter jejuni isolates from humans, poultry, and cattle. J Clin Microbiol (2000) 1.66

Extrachromosomal ribosomal RNA genes in Tetrahymena: structure and evolution. J Mol Biol (1979) 1.61

Complete amino acid sequence of human intestinal aminopeptidase N as deduced from cloned cDNA. FEBS Lett (1988) 1.59

Antimicrobial susceptibility patterns of thermophilic Campylobacter spp. from humans, pigs, cattle, and broilers in Denmark. Antimicrob Agents Chemother (1997) 1.58

The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules. Radiother Oncol (1994) 1.54

Serum syndecan-1: a new independent prognostic marker in multiple myeloma. Blood (2000) 1.54

Phylogenetic evidence for the acquisition of ribosomal RNA introns subsequent to the divergence of some of the major Tetrahymena groups. EMBO J (1986) 1.53

Time-dose factors in radiotherapy: a review of the human data. Radiother Oncol (1990) 1.51

Distribution of immunoglobulin-containing cells in human bone marrow and lymphoid tissues. Acta Med Scand (1976) 1.50

Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex. J Exp Med (2000) 1.49

Comparison of genotypes and serotypes of Campylobacter jejuni isolated from Danish wild mammals and birds and from broiler flocks and humans. Appl Environ Microbiol (2001) 1.46

Osteosarcoma in a 26-month-old girl. Cancer (1992) 1.45

The intervening sequence in the 26S rRNA coding region of T. thermophila is transcribed within the largest stable precursor for rRNA. Cell (1979) 1.44

Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group. Blood (2000) 1.43

Detailed transcription map of the extrachromosomal ribosomal RNA genes in Tetrahymena thermophila. J Mol Biol (1980) 1.41

Gene expression signatures for colorectal cancer microsatellite status and HNPCC. Br J Cancer (2005) 1.40

Molecular population genetic analysis of Campylobacter jejuni HS:19 associated with Guillain-Barré syndrome and gastroenteritis. J Infect Dis (2001) 1.40

Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. Proc Natl Acad Sci U S A (1998) 1.38

International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100). Leukemia (2009) 1.38

Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group. Blood (1998) 1.35

Antimicrobial resistance of thermophilic Campylobacter. Vet Res (2001) 1.34

An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma. Eur J Cancer (2007) 1.33

Spliceosomal small nuclear RNAs of Tetrahymena thermophila and some possible snRNA-snRNA base-pairing interactions. J Mol Biol (1991) 1.33

The genes for the eight subunits of the membrane bound ATP synthase of Escherichia coli. Mol Gen Genet (1981) 1.31

International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation. Leukemia (2009) 1.29

Optimization of uncomplicated control for head and neck tumors. Int J Radiat Oncol Biol Phys (1990) 1.26

Invasive listeriosis in Denmark 1994-2003: a review of 299 cases with special emphasis on risk factors for mortality. Clin Microbiol Infect (2005) 1.25

A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells. Proc Natl Acad Sci U S A (1996) 1.24

5' exon requirement for self-splicing of the Tetrahymena thermophila pre-ribosomal RNA and identification of a cryptic 5' splice site in the 3' exon. J Mol Biol (1987) 1.23

The nucleotide sequence at the transcription termination site of the ribosomal RNA gene in Tetrahymena thermophila. Nucleic Acids Res (1982) 1.21

Specification of dose delivery in radiation therapy. Recommendation by the Nordic Association of Clinical Physics (NACP). Acta Oncol (1997) 1.19

Ifosfamide and continuous infusion etoposide in advanced adult soft tissue sarcoma. A Scandinavian Sarcoma Group Phase II Study. Eur J Cancer (1997) 1.18

Clinical evidence of hypersensitivity to low doses in radiotherapy. Radiother Oncol (1996) 1.17

Strong sequence conservation of a 38 bp region near the center of the extrachromosomal rDNA palindrome in different Tetrahymena species. Nucleic Acids Res (1983) 1.17

Short-term and medium-term clinical outcomes of Campylobacter concisus infection. Clin Microbiol Infect (2012) 1.17

Metabolic studies of small molecular weight nuclear RNA components in BHK-21 cells. Biochim Biophys Acta (1974) 1.16

Induction of nucleolar and mitochondrial DNA replication in Tetrahymena pyriformis. Proc Natl Acad Sci U S A (1974) 1.16

An intron in a ribosomal protein gene from Tetrahymena. EMBO J (1986) 1.16

Evidence for individual differences in the radiosensitivity of human skin. Eur J Cancer (1992) 1.13

The ribosomal RNA genes of Tetrahymena: structure and function. Eur J Cell Biol (1985) 1.13

Genetic relatedness among Campylobacter jejuni serotyped isolates of diverse origin as determined by numerical analysis of amplified fragment length polymorphism (AFLP) profiles. J Appl Microbiol (2004) 1.13

Antibody responses to Campylobacter infections determined by an enzyme-linked immunosorbent assay: 2-year follow-up study of 210 patients. Clin Diagn Lab Immunol (2001) 1.12

A hybrid electroabsorption modulator device for generation of high spectral-efficiency optical modulation formats. Opt Express (2008) 1.11

Most Campylobacter subtypes from sporadic infections can be found in retail poultry products and food animals. Epidemiol Infect (2005) 1.11

High incidence of Campylobacter concisus in gastroenteritis in North Jutland, Denmark: a population-based study. Clin Microbiol Infect (2012) 1.10

Purification and characterization of the CopB replication control protein, and precise mapping of its target site in the R1 plasmid. Plasmid (1986) 1.10

Autonomous rDNA molecules containing single copies of the ribosomal RNA genes in the macronucleus of Tetrahymena pyriformis. Biochem Biophys Res Commun (1974) 1.10

Nucleotide sequence of the 5'-terminal coding region for pre-rRNA and mature 17S rRNA in Tetrahymena thermophila rDNA. Nucleic Acids Res (1984) 1.09

Isolation and DNA-RNA hybridization properties of small-molecular-weight nuclear RNA components from baby-hamster-kidney cells. Eur J Biochem (1974) 1.08

Nascent subribosomal particles in Tetrahymena pyriformis. Eur J Biochem (1970) 1.07

Comparison of trends in the incidence of multiple myeloma in Malmö, Sweden, and other countries, 1950-1979. N Engl J Med (1984) 1.07

HMO market structure and performance: 1985-1995. Health Aff (Millwood) (1998) 1.07

Tetrahymena thermophila acidic ribosomal protein L37 contains an archaebacterial type of C-terminus. Gene (1991) 1.06

Molecular cloning and functional characterization of a copy number control gene (copB) of plasmid R1. J Bacteriol (1982) 1.05

Describing patients' normal tissue reactions: concerning the possibility of individualising radiotherapy dose prescriptions based on potential predictive assays of normal tissue radiosensitivity. Steering Committee of the BioMed2 European Union Concerted Action Programme on the Development of Predictive Tests of Normal Tissue Response to Radiation Therapy. Int J Cancer (1998) 1.05

Different features of the MHC class I heterodimer have evolved at different rates. Chicken B-F and beta 2-microglobulin sequences reveal invariant surface residues. J Immunol (1992) 1.04

Purification and characterization of a Serratia marcescens nuclease produced by Escherichia coli. Carlsberg Res Commun (1989) 1.03

Sequence comparison of the rDNA introns from six different species of Tetrahymena. Nucleic Acids Res (1985) 1.03

Dynamics of irradiation injury to bone tissue. A vital microscopic investigation. Acta Radiol Oncol (1985) 1.03

Does the interval between fractions matter in the range of 4-8 h in radiotherapy? A study of acute and late human skin reactions. Radiother Oncol (1995) 1.02

Efficient method for constructing comprehensive murine Fab antibody libraries displayed on phage. Nucleic Acids Res (1993) 1.02

Factor VIII antigen in the vessel walls in von Willebrand's disease and haemophilia A. Scand J Haematol (1974) 1.02

Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support. Med Oncol (2001) 1.01

Structural organization of the genes encoding the small nuclear RNAs U1 to U6 of Tetrahymena thermophila is very similar to that of plant small nuclear RNA genes. J Mol Biol (1992) 0.99

Pharmacokinetics of thalidomide in patients with impaired renal function and while on and off dialysis. J Pharm Pharmacol (2003) 0.99

The amount of ribosomal RNA genes in Tetrahymena pyriformis in different physiological states. Eur J Biochem (1972) 0.99

Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer. Int J Radiat Oncol Biol Phys (1995) 0.99

Small nuclear RNAs in the ciliate Tetrahymena. Nucleic Acids Res (1985) 0.98

Dominant mode of inheritance in atrial septal defect. Clin Genet (1971) 0.97

Transcription and its regulation in the basic replicon region of plasmid R1. Mol Gen Genet (1985) 0.97

The influence of irradiation time per treatment session on acute and late skin reactions: a study on human skin. Radiother Oncol (1984) 0.96

Epidemiology and prognosis in children treated for intracranial tumours in Denmark 1960-1984. Childs Nerv Syst (1998) 0.96

Cerebral oedema as a possible complication of treatment with imatinib. Lancet (2002) 0.94

An IgM monoclonal protein with multiple serological specificities. Clin Exp Immunol (1979) 0.93

Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity. Lancet (1992) 0.93

DNA synthesis following refeeding of starved Tetrahymena pyriformis GL: starved cells are arrested in G 1. Exp Cell Res (1974) 0.93

Updating rDNA restriction enzyme maps of Tetrahymena reveals four new intron-containing species. J Protozool (1985) 0.92

Genotypic and serotypic stability of Campylobacter jejuni strains during in vitro and in vivo passage. Int J Med Microbiol (2001) 0.92

Integration of titanium implants in irradiated bone. Histologic and clinical study. Ann Otol Rhinol Laryngol (1988) 0.92

Functional characterization of HLA-DRA1*0101/DRB1*0401 molecules expressed in Drosophila melanogaster cells. Tissue Antigens (1998) 0.91

Interferon alfa-2b versus no maintenance therapy during the plateau phase in multiple myeloma: a randomized study. Cooperative Study Group. Br J Haematol (1995) 0.89

The chicken beta 2-microglobulin gene is located on a non-major histocompatibility complex microchromosome: a small, G+C-rich gene with X and Y boxes in the promoter. Proc Natl Acad Sci U S A (1996) 0.89

Temporofacial zygomycosis in a pregnant woman. Infection (1992) 0.88